Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: J Thromb Thrombolysis

Search In Journal Title:

Abbravation: Journal of Thrombosis and Thrombolysis

Search In Journal Abbravation:

Publisher

Springer US

Search In Publisher:

DOI

10.1007/bf00467587

Search In DOI:

ISSN

1573-742X

Search In ISSN:
Search In Title Of Papers:

Prognostic significance of multidetector computed

Authors: David Jiménez José Luis Lobo Manuel Monreal Remedios Otero Roger D Yusen
Publish Date: 2012/03/20
Volume: 34, Issue: 2, Pages: 187-192
PDF Link

Abstract

The PROTECT study is designed to assess the prognostic significance of multidetector computed tomography MDCT findings in normotensive outpatients with pulmonary embolism PE MDCT assesses right ventricular dysfunction RVD by measuring the ratio of the righttoleft ventricular short axis diameters The study uses 30day allcause mortality as the primary outcome The study determined inter and intraobserver reproducibility of CT findings of RVD According to the local radiologists’ measurements 44  of patients 42/96 showed RVD defined as a ratio of the RV to the LV short axis greater than 09 The intraclass correlation was good 0773 CI 95  0678–0842 For interobserver reproducibility the weighted kappa measurement was 0730 Intraobserver reproducibility was very good 0932 95  CI 0880–0962 The PROTECT study is designed to show the prognostic significance of MDCT for PE Inter and intraobserver agreement of interpretation of RVD were goodConsolación Rodríguez Jorge Vivancos Jesús Marín Bormujos Mikel Oribe Aitor Ballaz Jose María Abaitúa Sonia Velasco Galdakao Manuel Barrón María Lladó Carmen Rodrigo Luis Javier Alonso Logroño Ramón Rabuñal Olalla Castro Concepción Iglesias Ana Testa Lugo David Jiménez Vicente Gómez Luis Gorospe Sem Briongos José Manuel del Rey Madrid Celso Álvarez Nuria Rodríguez Amador Prieto María Martín Oviedo Carmen Navarro Mónica López Eva Castañer Eva Guillaumet Sabadell Remedios Otero Teresa Elías Pilar Serrano Francisco López Sevilla Reina Valle María Victoria Piret Pilar Lucio José María Cuesta Sierrallana Dolores Nauffal Marta Ballester José Pamies Ana Osa Valencia José Luis Lobo Vanesa Zorrilla Delfina Pozo Ángel Alonso Vitoria Francisco Conget Miguel Ángel Santolaria Mariano González José Luis de Benito Zaragoza

Keywords:

References

.
Search In Abstract Of Papers:
Other Papers In This Journal:
  1. The inhibition in tumor necrosis factor-α-induced attenuation in endothelial thrombomodulin expression by carvedilol is mediated by nuclear factor-κB and reactive oxygen species
  2. Comparison of platelet inhibition by prasugrel versus ticagrelor over time in patients with acute myocardial infarction
  3. Does supervised exercise after deep venous thrombosis improve recanalization of occluded vein segments? A randomized study
  4. Anticoagulation in the management of venous thromboembolism in the cancer patient
  5. Association between sleep condition and arterial stiffness in Chinese adult with nonalcoholic fatty liver disease
  6. In vitro shear stress modulates antithrombogenic potentials of human endothelial progenitor cells
  7. Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease
  8. Role of thrombophilia testing: con
  9. Venous thromboembolism and cancer: a systematic review
  10. Dabigatran-associated subdural hemorrhage: using thromboelastography (TEG ® ) to guide decision-making
  11. Proceedings of the 10th National Conference on Anticoagulant Therapy
  12. Comparative efficacy of in vitro and in vivo metabolized aspirin in the DeBakey ventricular assist device
  13. The relationship between gender and age with monocyte tissue factor expression
  14. Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability
  15. A comparison of direct thrombin inhibitors in the treatment of heparin-induced thrombocytopenia: a single institution experience
  16. US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins
  17. Measurement of dabigatran and rivaroxaban in primary prevention of venous thromboembolism in 106 patients, who have undergone major orthopedic surgery: an observational study
  18. Abnormal asymmetric dimethylarginine/nitric oxide balance in patients with documented coronary artery disease: relation to renal function and homocysteine
  19. Tailoring clopidogrel dose according to multiple electrode aggregometry decreases the rate of ischemic complications after percutaneous coronary intervention
  20. Cardiovascular risk factors and outcome in patients with retinal vein occlusion
  21. Impact of type of thrombolytic agent on in-hospital outcomes in ST-segment elevation myocardial infarction patients in the Middle East
  22. Increased platelet activation in patients with slow coronary flow
  23. Biomarkers of deep venous thrombosis
  24. Thromboembolic complications following a first isolated episode of superficial vein thrombosis: a cross-sectional retrospective study
  25. The impact of factor Xa inhibition on axial dependent arterial thrombus formation triggered by a tissue factor rich surface
  26. New oral Xa and IIa inhibitors: updates on clinical trial results
  27. Spontaneous coronary thrombosis following thrombolytic therapy for acute cardiovascular accident and stroke: a case study
  28. Anti-coagulant activity of a metalloprotease: further characterization from the Indian cobra ( Naja naja ) venom
  29. Evaluation of the Alere D-dimer test for point of care testing
  30. Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves
  31. Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial
  32. Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism
  33. Methylenetetrahydrofolate reductase (MTHFR) C677T genetic polymorphism and late infarct-related coronary artery patency after thrombolysis
  34. Are surgical patients at risk of venous thromboembolism currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely prophylaxis?
  35. Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait
Search Result: